L21 Multiple Sclerosis Flashcards

1
Q

What is one factor that contributes to the prevalence of multiple sclerosis?

A

As you move farther from the equator, the prevalence goes up, and this may be due to the vitamin D deficiency hypothesis.
Not enough vitamin D leads to increased rates of MS, in the world and also in countries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are four different effects in the neurons that accompanies MS?

A

Demyelination, axonal loss, axonal degeneration, inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does the age distribution of MS look like?

A

Hits the younger generation more, peaks at around 25-30.
Different from other neurodegenerative diseases (15-45)
Low prevalence around 10 and 60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the prevalence of pediatric MS?

A

6% of MS in total is pediatric, 3-10% of MS patients see an onset at 18 yrs old or younger
Age of onset affects disease progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Is there a gender difference in the prevalence of MS?

A

YES
Female to male ratio is 3:1, but males have a later onset and more progressive disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the three categories of MS?

A

Primary progressing: 10% of people, slow and continuous progression of the disease
Secondary progressing: happens after R and R type (80% of people)
Relapse/remitting (usually turns into SP): flare, recover, flare, recover, and recover less every time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What scale is used to score MS patients on their degree of disability?

A

Expanded Disability Status Scale (EDSS), used for motor disability
From 0-10, 10 being the highest level of disability, different milestones are used such as requiring assistance to walk (6), restricted to a wheelchair (7), restricted to bed/chair (8), confined to bed (9), and death is 10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the pathology of MS?

A

Demyelination of axons, many lesions in different parts of the brain (usually localized)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the pathway for treatment in MS?

A

MS involved demyelination of axons, and to repair this you can either remyelinate the neurons.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the pathology of an MS plaque?

A

Decreased axonal density in the lesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are potential causes of MS?

A

Genes
Smoking
Infections (not necessarily a cause, associated with EBV (mono), but 78% of the population has had this and they do not all have MS)
Salt can increase inflammation and activation of the immune system, thus increasing MS
Vitamin D deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What do genes contribute to MS?

A

It is not genetically transmitted, it is associated with DRB gene but it is not causal, simple a predisposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is EAE and what it is immune pathology?

A

EAE is a demyelinating disease that can be transferred between mice via transfer of lymphocytes from sick mouse to healthy mouse.
First you get naive MBP recognizing T-cells that are activated by MBP on antigen presenting cells. They are then differentiated into Th1, Th2, Th17 and T regulatory cells (all release cytokines and initiate inflammation), which cross the blood brain barrier into the CNS, along with B cells that further activate T-cells and these lead to chronic inflammation, demyelination and axonal damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are 8 things that happen and contribute to the pathogenesis of MS?

A

Astrocyte activation, neuro-axonal degeneration, excitotoxicity, microglia activation, energy failure, inflammation, ionic imbalance and increased sodium balance, demyelination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What type of brain atrophy do you see in Ms?

A

Loss of white matter AND grey matter, get big ventricles filled with fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Are reflexes disrupted by MS?

A

YES
The reflex arc is disrupted and can result in spasticity by sudden release of the system (hard to sleep and sit still)

17
Q

What are 3 common effects of MS?

A

Fatigue: feeling of physical tiredness and lack of energy distinct from sadness or weakness, worst symptoms of the disease in many people (50-60% of people)
Bladder dysfunction: could be overactivity (urgency/frequency/urge/incontinence), inefficiency (incomplete emptying, residual urine, retention), detrusor-sphincter dyssynergia (co-contraction of bladder and urethral sphincter) affects 75% of people
Pain: persistent neurogenic pain which is burning dysesthesia of limbs or trunk attributed to disruption of spinothalamic pathway, paroxysmal neurogenic pain (trigeminal neuralgia) which are episodes of excruciating nerve pain
40-50% of patients are affected

18
Q

What are some treatments for MS?

A

Existing treatment primarily target the inflammatory component of MS
There is a need for novel agents that directly target protection and repair of CNS AND targeting inflammation (want to decrease demyelination, neurodegeneration, failure of repair/gliosis)

19
Q

What are the 4 available treatments for MS in 2023? What is one experimental one?

A

Traditional injectables: earliest treatments
Oral therapies: good because no need for injection
Monoclonal antibodies: selective suppressors, do not suppress entire immune system
Chemotherapies: RISKY because may cause cancer
Experimental: autologous stem cell transplant, bone narrow transplant

20
Q

What are the three traditional immunomodulatory therapies that were made in the 1990s?

A
  1. Interferon
  2. IFNB1A
  3. Glatiramer acetate
21
Q

What is the mechanism of action of Interferon beta?

A

Acts through the interferon-beta receptor and inhibits antigen presentation and T-cell activation, therefore reducing the amount of pro-inflammatory cytokines

22
Q

What is the mechanism of action of Glatiramer Acetate (GA)?

A

It is presented as an antigen and is therefore taken up and presented by an APC, therefore making GA-specific T cells of Th2 bias

23
Q

How do immunomodulators treat MS?

A

Immunomodulators help to decrease the inflammatory immune response, such as TERF which prevents the differentiation of naive T-cells into pro-inflammatory ones, and the same can be said for DMF

24
Q

How do traffickers help with MS?

A

THey stop the migration of immune cells into the BBB and the CNS, therefore no inflammation
BUT this means that there is no immunity in the brain and it is susceptible to other viruses and infections
FINGO: regulates the exit of lymphocytes from lymph nodes

25
Q

How does an immuno-depleter help with MS?

A

Decreases activation of inflammatory cells and kills them, therefore no inflammation in the CNS

26
Q

What is the general trend for efficacy and safety of MS meds?

A

The stronger and more effective they are, the less safe they are, and vice versa